Medical News

RSS

Jim Stynes battle with cancer documentary to inspire people

Jim Stynes, the former AFL football star said he was motivated to participate in a documentary about his life and his battle with cancer to inspire people. The 1991 AFL Brownlow Medallist and current chairman of Melbourne Football Club is more than a year into his battle with cancer.

14 Sep 2010

Professor Nygren reviews current state of IVF safety

Now a review by the Chair of the international body which collects data on IVF concludes that IVF is generally safe, although he stresses that patients need to be made aware of the slight risks, and that we need to continue to monitor the results of the technique.

14 Sep 2010

Researchers review clerkship performance records of medical students at four colleges

Susan M. Kies, Ed.D., of the University of Illinois College of Medicine, Urbana, and colleagues conducted a study to assess whether the order in which third-year core clerkships are completed affects student performance.

14 Sep 2010

Study to identify demographic variables prior to medical school acceptance

Dorothy A. Andriole, M.D., and Donna B. Jeffe, Ph.D., of Washington University, St. Louis, conducted a study to identify demographic variables prior to medical school acceptance associated with outcomes for medical school students.

14 Sep 2010

Dana-Farber doctor hosts live program on Twitter to discuss head and neck cancers

The recent news that Michael Douglas has been diagnosed with stage 4 throat cancer has raised public awareness of head and neck cancer. What causes throat cancer and what are the symptoms? Are there ways to prevent or reduce the risk of throat cancer? How is the human papillomavirus (HPV) related to oral cancer?

14 Sep 2010

Pepscan, Tibotec sign Research and License Agreement

Pepscan Therapeutics, the Netherlands based biotechnology firm focusing on protein mimicry technology for the generation of novel therapeutics, today announced that it has signed a Research and License Agreement with Tibotec Pharmaceuticals, Ireland. Under the agreement Pepscan using its CLIPS technology will work with Tibotec to develop novel therapeutic peptides against an undisclosed target.

14 Sep 2010

Cetaphil launches Restoraderm for management of eczema and atopic dermatitis skin

The Cetaphil® brand, the #1 dermatologist-recommended brand of cleansers and moisturizers announced the launch of Cetaphil® Restoraderm® products, formulated specifically for the needs of eczema and atopic dermatitis skin. Cetaphil® Restoraderm® Skin Restoring Body Wash and Skin Restoring Moisturizer soothes itching associated with skin affected by eczema and atopic dermatitis.

14 Sep 2010

Lakeland second-quarter revenue increases 6.5% to $24.6 million

Lakeland Industries, Inc. today announced financial results for its second quarter fiscal year 2011 ended July 31, 2010.

14 Sep 2010

Planet Beach launches lower investment version of Contempo Spa franchise

Planet Beach Franchising Corporation, a recognizable leader in the health, wellness and beauty industry, has launched a lower investment version of its successful Contempo Spa franchise.

14 Sep 2010

Parents struggle to balance emotional, rational aspects of immunization: Poll

Back-to-school is in full swing and parents are breathing a collective sigh of relief now that their kids are back in the classroom. But with the back-to-school rush comes the reminder that immunizations must be updated - and that thought has parents filled with anything but relief. In fact, according to a new poll of Ontarians, parents struggle emotionally with immunizing their children - and themselves - before making the decision to do so.

14 Sep 2010

Target shoppers can help St. Jude's in fight against cancer, catastrophic diseases

Many of the public's favorite household brands have joined forces to support the lifesaving work of St. Jude Children's Research Hospital, one of the world's premier pediatric cancer research centers. From September 19 - 25, Target guests can help St. Jude in its fight to find cures and save children with cancer and other catastrophic diseases by purchasing participating Procter & Gamble (P&G) brands including Tide, Charmin, Bounty and Pampers as well as other manufacturers' brands at Target stores nationwide.

14 Sep 2010

UBM Live anticipates CPhI Worldwide attendance to exceed 25,000

Leading events organiser UBM Live today announced that it expects the attendance for CPhI Worldwide, the annual flagship tradeshow for pharma ingredients, now in its 21st year and the year being held in Paris, to exceed the 25,000 seen at last year's event, held in Madrid.

14 Sep 2010

TeleHealth Services announces new partnership with TRHMC to improve patient experience

TeleHealth Services, the nation's leading provider of healthcare grade televisions and interactive patient education solutions, today announced a new partnership with The Reading Hospital and Medical Center. The 671-bed hospital chose TeleHealth Services as their interactive patient education and entertainment partner as an extension of the hospital's Surgical Care Improvement Project.

14 Sep 2010

CSC launches new educational program to enhance lymphoma patient, physician communication

The Cancer Support Community (CSC), uniting The Wellness Community and Gilda's Club Worldwide, announced today the launch of Framing Life With Lymphoma, a new educational program designed to enhance lymphoma patient and physician communication.

14 Sep 2010

GenVec completes initial milestone in collaboration with Novartis

GenVec, Inc. today announced that it has achieved the first milestone in its collaboration with Novartis, related to the development of treatments for hearing loss and balance disorders. The milestone was triggered by the successful completion of certain preclinical development activities.

14 Sep 2010

Life Technologies finalizes cell line license agreement for recombinant protein production

Life Technologies Corporation today announced that it has finalized cell line license agreements with a number of companies to provide rights to Life Technologies' proprietary CHO (Chinese hamster ovary) cell lines for the production of recombinant proteins used as therapeutic agents and vaccines.

14 Sep 2010

Data from Phase II trial of zanolimumab in PTCL published in British Journal of Haematology

TenX Biopharma, Inc. announced today that data from a Phase II trial of zanolimumab (HuMax-CD4®) in peripheral T-cell Lymphoma were published in the British Journal of Haematology (Sep 2010: 150(5):565-73). The Hx-CD4-109 trial was designed to evaluate the safety and efficacy of zanolimumab in patients who have relapsed or refractory non-cutaneous peripheral T-cell lymphoma.

14 Sep 2010

Gentium announces defibrotide presentations at 33rd World Congress of International Society of Hematology

Gentium S.p.A. today announced that two posters and one oral presentation on defibrotide will be presented at the 33rd World Congress of International Society of Hematology to be held at the ICC Jerusalem International Convention Center in Jerusalem, Israel, October 10-13, 2010.

14 Sep 2010

Stemedica Cell Technologies completes master bank of mesenchymal bone marrow-derived stem cells

Stemedica Cell Technologies, Inc., a world leader in adult stem cell manufacturing and research, announced today that it has completed its proprietary master bank of mesenchymal bone marrow-derived stem cells.

14 Sep 2010

Enrollment in Derma Sciences DSC127 Phase 2 trial in diabetic foot ulcer healing to conclude September end

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced that patient screening in its DSC127 Phase 2 trial in diabetic foot ulcer healing will be completed tomorrow, and that enrollment in the trial will conclude on September 30. This randomized, double-blind, placebo controlled study of up to 75 patients will look at the percentage of diabetic ulcers completely healed over a 12-week period, among other outcomes.

14 Sep 2010

Medical News

Jim Stynes battle with cancer documentary to inspire people

Professor Nygren reviews current state of IVF safety

Researchers review clerkship performance records of medical students at four colleges

Study to identify demographic variables prior to medical school acceptance

Dana-Farber doctor hosts live program on Twitter to discuss head and neck cancers

Pepscan, Tibotec sign Research and License Agreement

Cetaphil launches Restoraderm for management of eczema and atopic dermatitis skin

Lakeland second-quarter revenue increases 6.5% to $24.6 million

Planet Beach launches lower investment version of Contempo Spa franchise

Parents struggle to balance emotional, rational aspects of immunization: Poll

Target shoppers can help St. Jude's in fight against cancer, catastrophic diseases

UBM Live anticipates CPhI Worldwide attendance to exceed 25,000

TeleHealth Services announces new partnership with TRHMC to improve patient experience

CSC launches new educational program to enhance lymphoma patient, physician communication

GenVec completes initial milestone in collaboration with Novartis

Life Technologies finalizes cell line license agreement for recombinant protein production

Data from Phase II trial of zanolimumab in PTCL published in British Journal of Haematology

Gentium announces defibrotide presentations at 33rd World Congress of International Society of Hematology

Stemedica Cell Technologies completes master bank of mesenchymal bone marrow-derived stem cells

Enrollment in Derma Sciences DSC127 Phase 2 trial in diabetic foot ulcer healing to conclude September end

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

The importance of ketones from a clinical and medical perspective

Latest News